Investor Relations > Financials > Earnings Guidance

FY2025–2027 Earnings & Operational Guidance

Strategic financial outlook, margin expansion targets, and capital allocation framework

Forward-Looking Statements | Updated Q4 2024
Revenue Growth (CAGR)
9.2%
Target: $101.8B (FY25)
EPS Guidance (Diluted)
$9.15
Target: +8.7% YoY
EBITDA Margin
25.1%
Target: 140bps expansion
Free Cash Flow
$31.2B
Target: 30.6% FCF Yield
R&D Investment
12.8%
Target: $13.0B CapEx

Financial Projections & Key Metrics

Metric FY2024 Actual FY2025 Guidance YoY Change Confidence Level
Total Revenue $94.2B $101.8B +8.1% High
Diluted EPS $8.42 $9.15 +8.7% Medium-High
EBITDA $22.9B $25.5B +11.4% High
EBITDA Margin 24.3% 25.1% +80bps Medium
Operating Cash Flow $38.4B $41.2B +7.3% High
Capital Expenditures $14.2B $15.8B +11.3% High
Net Debt / EBITDA 1.8x 1.6x -0.2x Medium
Metric FY2025 Guidance FY2026 Outlook YoY Change Confidence Level
Total Revenue $101.8B $112.4B +10.4% Medium
Diluted EPS $9.15 $10.32 +12.8% Medium
EBITDA $25.5B $29.2B +14.5% Medium
EBITDA Margin 25.1% 26.0% +90bps Medium
Operating Cash Flow $41.2B $45.8B +11.2% Medium
Capital Expenditures $15.8B $17.1B +8.2% Medium
Net Debt / EBITDA 1.6x 1.4x -0.2x Medium
Metric FY2026 Outlook FY2027 Projection YoY Change Confidence Level
Total Revenue $112.4B $123.6B +9.9% Low-Medium
Diluted EPS $10.32 $11.85 +14.8% Low-Medium
EBITDA $29.2B $32.8B +12.3% Low-Medium
EBITDA Margin 26.0% 26.5% +50bps Low-Medium
Operating Cash Flow $45.8B $50.2B +9.6% Low-Medium
Capital Expenditures $17.1B $18.4B +7.6% Low-Medium
Net Debt / EBITDA 1.4x 1.2x -0.2x Low-Medium

Divisional Revenue & Margin Outlook

Aevum Energy & Power +9.2% Rev

Driven by grid modernization contracts and fusion research commercialization milestones. Margin expansion expected from operational leverage.

Margin: 28.4% CapEx: $4.2B
Zenth Digital Systems +14.1% Rev

Enterprise AI adoption and quantum cloud services accelerating. High-margin software licensing offsets hardware cycle volatility.

Margin: 34.6% CapEx: $3.1B
Aerospace & Defense +11.3% Rev

Satellite constellation deployment and hypersonic propulsion contracts. Long-cycle defense agreements provide revenue visibility.

Margin: 22.8% CapEx: $3.8B
Zenth Health Sciences +12.5% Rev

Gene therapy approvals and telemedicine network expansion. R&D pipeline monetization expected to lift margins by 110bps.

Margin: 26.1% CapEx: $2.4B
Aevum Capital Group +7.4% Rev

Wealth management AUM growth and fintech platform scaling. Interest rate environment normalizing fee income stability.

Margin: 41.2% CapEx: $1.1B
Logistics & Infrastructure +8.6% Rev

Autonomous freight rollout and smart port integrations. Margin pressure from fuel hedging offset by automation savings.

Margin: 19.7% CapEx: $1.2B

Forward-Looking Statements & Risk Factors

Macroeconomic & Market Volatility

Our financial projections assume continued global economic expansion, stable currency exchange rates, and manageable inflationary pressures. Adverse macroeconomic shifts, geopolitical tensions, or supply chain disruptions could materially impact revenue realization, cost structures, and working capital requirements across multiple divisions. Sensitivity models indicate a 5% GDP contraction would reduce FY25 revenue guidance by approximately 2.1–2.8%.

Regulatory & Compliance Changes

Operating across 47 industries in 62 jurisdictions exposes Aevum Zenth to evolving regulatory frameworks, particularly in data privacy, environmental compliance, defense contracting, and financial services. Unanticipated regulatory changes could require incremental compliance expenditures, delay product launches, or restrict market access in key regions.

Technology Execution & R&D Commercialization

Guidance incorporates expected milestones in fusion energy, quantum computing, and autonomous systems. Delays in technical validation, intellectual property challenges, or commercial adoption friction could extend payback periods and temporarily compress margins. We maintain a 12–18 month buffer in CapEx allocation to mitigate execution risk.

Standard Safe Harbor Disclaimer

This material contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to risks and uncertainties detailed in our SEC filings, including Form 10-K and periodic 8-K reports. Aevum Zenth undertakes no obligation to update forward-looking statements except as required by law. Past performance is not indicative of future results.

Investor Relations

For detailed financial models, presentation decks, or analyst inquiries:

ir@aevumzenth.com | +1 (212) 555-0198

Download FY25 Data Book (PDF) Schedule IR Call